Dawn Carter Bir, Chief Commercial Officer: Reata Pharmaceuticals RETA Sell · Filed 23/08/17

Trade details

Type: Insider sale
Amount: $136,415.28
Shares · price: 807 sh · $169.04 a share
Held after: 34,203 sh
Stock: Reata Pharmaceuticals RETA
Person: Dawn Carter BirChief Commercial Officer
Trade date: 23/08/15
Filed: 23/08/17
Days to filing: 2 days

Sold 2.3% of holdings

Share of holding sold: 2.3%

Reata Pharmaceuticals trades, last 26 weeks

What else happened in Reata Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/07/16~23/09/14

Dawn Carter Bir's recent trades

Dawn Carter BirChief Commercial Officer
SellReata Pharmaceuticals
Sell
Reata Pharmaceuticals
RETA
$67K
398 sh
$67K
Filed 23/08/17
Traded 23/08/16
Dawn Carter BirChief Commercial Officer
Sell10b5-1 planReata Pharmaceuticals
Sell10b5-1 plan
Reata Pharmaceuticals
RETA
$6.6M
40,000 sh
$6.6M
Filed 23/08/01
Traded 23/07/28
Dawn Carter BirChief Commercial Officer
SellReata Pharmaceuticals
Sell
Reata Pharmaceuticals
RETA
$76.1K
894 sh
$76.1K
Filed 23/05/17
Traded 23/05/15
Dawn Carter BirChief Commercial Officer
SellReata Pharmaceuticals
Sell
Reata Pharmaceuticals
RETA
$33.8K
417 sh
$33.8K
Filed 23/05/17
Traded 23/05/16
Dawn Carter BirChief Commercial Officer
SellReata Pharmaceuticals
Sell
Reata Pharmaceuticals
RETA
$808.4K
9,317 sh
$808.4K
Filed 23/03/15
Traded 23/03/13

Dawn Carter Bir, Chief Officer — sold $136.4K of Reata Pharmaceuticals RETA · 2.3% of holdings | Whalegun